[P4–003]: A RANDOMIZED, PLACEBO‐CONTROLLED, CROSS‐OVER TRIAL INVESTIGATING NABILONE AS A TREATMENT FOR AGITATION IN PATIENTS WITH MODERATE‐TO‐SEVERE ALZHEIMER'S DISEASE: BLINDED, INTERIM SAFETY RESULTS
Moderate to severe medicine.medical_specialty Epidemiology business.industry Health Policy Disease 030204 cardiovascular system & hematology Placebo Crossover study Nabilone 03 medical and health sciences Psychiatry and Mental health Cellular and Molecular Neuroscience 0302 clinical medicine Developmental Neuroscience Interim Internal medicine medicine In patient 030212 general & internal medicine Neurology (clinical) Geriatrics and Gerontology business medicine.drug